Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral ciprofloxacin for osteomyelitis.

R R MacGregor1, A L Graziani, J L Esterhai

  • 1Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.

Orthopedics
|January 1, 1990
PubMed
Summary

Ciprofloxacin effectively treated osteomyelitis in 18 patients, with over 60% achieving infection arrest. This broad-spectrum antibiotic demonstrated good tolerability and a favorable safety profile in the study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2013
Same author

Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2013
Same author

Supplemental Feeding in Gastro-Intestinal Disturbances of the Breast Fed Infant.

Canadian Medical Association journal·2010
Same author

A Case of Amaurotic Family Idiocy.

Canadian Medical Association journal·2010
Same author

A Case of Amyotonia Congenita.

Canadian Medical Association journal·2010
Same author

SOME INTERESTING CASES OF HYPERTROPHIC PYLORIC STENOSIS.

Canadian Medical Association journal·2010

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Orthopedic Surgery

Background:

  • Osteomyelitis presents a significant treatment challenge, often requiring prolonged antibiotic courses.
  • Broad-spectrum antibiotics with favorable pharmacokinetic profiles are crucial for managing bone infections.
  • Ciprofloxacin, a fluoroquinolone, offers potential advantages in treating complex infections like osteomyelitis.

Observation:

  • Eighteen patients diagnosed with osteomyelitis were administered ciprofloxacin (750 mg orally twice daily).
  • Treatment duration varied significantly, ranging from 5 to 52 weeks.
  • Patient demographics included a mean age of 43 years, with 12 males.

Findings:

  • A majority of patients (61.6%) achieved complete arrest of osteomyelitis infection.
  • An additional 22.2% showed improvement in their condition with ciprofloxacin therapy.
  • The antibiotic was generally well-tolerated, with a low incidence of adverse events reported.

Implications:

  • Oral ciprofloxacin presents a viable and effective therapeutic option for osteomyelitis management.
  • The drug's tolerability supports its use in long-term treatment regimens for bone infections.
  • Further research can explore ciprofloxacin's role in diverse osteomyelitis patient populations and settings.

Related Experiment Videos